Forecasts data is unavailable for this security.
Consensus recommendation
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 0 | |
Outperform | 1 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in CAD
The one analyst offering a 12 month price target expects NervGen Pharma Corp share price to rise to 4.00 in the next year from the last price of 2.72.
High | 47.1% | 4.00 |
Med | 47.1% | 4.00 |
Low | 47.1% | 4.00 |
Earnings history & estimates in CAD
The next earnings announcement is expected on Nov 07, 2024.
Average growth rate | -25.38% |
Average growth rate | -11.62% |
More ▼
Revenue history & estimates in CAD
Average growth rate | -20.00% |
Average growth rate | 0.00% |
More ▼